SAN MATEO, Calif., June 10, 2024 /PRNewswire/ -- Cala, the bioelectronic medicine leader, reached a major milestone: a positive Medicare...
Board consists of key opinion leaders from both clinical practice and academia with strong track records in the development of...
June 10, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial...
Preclinical data highlights the therapeutic potential of Ashvattha’s novel CSF1R tyrosine kinase inhibitor (CSF1R dendranib) for multiple sclerosis (MS) based...
Global early-stage fund to catalyze development of the next generation of treatments Backers include the leading spinal cord injury foundations...
ORLANDO, Fla., June 7, 2024 /PRNewswire/ -- Monotype, one of the most recognized names in the world of fonts and...
CARMEL, Ind., June 07, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
MUNICH, June 6, 2024 /PRNewswire/ -- According to the World Health Organization (WHO), at least 80 million people (or 1%...
MOUNTAIN VIEW, Calif., June 6, 2024 /PRNewswire/ -- NextSense is proud to announce that it has been recognized as a...
New Longevity Tech Collaboration Will Research and Develop First-Ever Biological Clock for the Brain WHISTLER, BC, June 6, 2024 /PRNewswire/...
SAN DIEGO, June 6, 2024 /PRNewswire/ -- ScienceMedia announced today that it has formed a partnership with UL Solutions that...
TORONTO, ON / ACCESSWIRE / June 6, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical...
Company expects to lock database in June andremains on track to report key outcomes later in July. Pepinemab targets astrocyte...
Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"),...
NEW YORK, June 5, 2024 /PRNewswire/ -- QuantalX Neuroscience Ltd, a pioneering medical technology company, is delighted to announce its...
Collaborative Partnership Designed to Enhance Nationwide Efforts to Combat the Opioid Epidemic and Improve Addiction RecoveryIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI),...
- Company positioning multiple assets for late-stage development across its therapeutic pipeline – BOSTON and ATLANTA, June 05, 2024 (GLOBE...
MALVERN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”),...
Continued sector investment and M&A will reshape the vendor landscape to be driven by artificial intelligence (AI), replacing ineffective EMRs...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation...